Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Scandinavian ChemoTech

3.70 SEK

-1.07 %

Less than 1K followers

CMOTEC B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-1.07 %
-31.48 %
+4.82 %
+78.74 %
+106.70 %
+135.67 %
-30.99 %
-65.15 %
-90.18 %

Scandinavian ChemoTech is a Swedish company that develops and markets medical technology based on electrochemotherapy for the treatment of cancer. The company offers systems and solutions to clinics in oncology and veterinary medicine and has operations in international markets, including India and Southeast Asia. The company was founded in 2015 and is headquartered in Lund, Sweden.

Read more
Market cap
94.18M SEK
Turnover
216.21K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
3.3.
2026

Annual report '25

All
Press releases
ShowingAll content types
Regulatory press release10 hours ago

ChemoTech's Animal Care Announces First U.S. Order from Leading Equine Clinic in Kentucky

Scandinavian ChemoTech
Press release11/5/2025, 10:14 AM

Redeye: Scandinavian ChemoTech (Q3 Review) - Strong momentum in revenue from treatment kits

Scandinavian ChemoTech
Regulatory press release11/4/2025, 7:03 AM

Scandinavian ChemoTech AB (publ) publishes Interim Report Q3 2025

Scandinavian ChemoTech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Press release10/17/2025, 6:40 AM

Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide

Scandinavian ChemoTech
Regulatory press release10/1/2025, 12:43 PM

ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown

Scandinavian ChemoTech
Press release9/26/2025, 1:35 PM

ChemoTech's Animal Care Successfully Enters Swiss Market as Part of DACH Expansion

Scandinavian ChemoTech
Press release9/19/2025, 1:21 PM

Scandinavian ChemoTech Hosts Successful TSE Best Practice Sharing Session with Dr. Brendan Boostrom

Scandinavian ChemoTech
Regulatory press release9/12/2025, 5:23 AM

ChemoTech's Animal Care Expands University Partnerships with SLU Equine Hospital in Ultuna

Scandinavian ChemoTech
Press release8/25/2025, 1:15 PM

Scandinavian ChemoTech Expands in Florida with Fourth Veterinary Oncology Clinic Partnership

Scandinavian ChemoTech
Regulatory press release8/20/2025, 9:50 AM

Scandinavian ChemoTech's Animal Care Surpasses 2,500 Treatment-kits sold Worldwide

Scandinavian ChemoTech
Press release8/14/2025, 2:21 PM

Redeye: Scandinavian ChemoTech - Growth tailwinds

Scandinavian ChemoTech
Regulatory press release8/12/2025, 6:05 AM

Scandinavian ChemoTech AB (publ) publishes Interim Report Q2 2025

Scandinavian ChemoTech
Press release7/29/2025, 12:31 PM

Scandinavian ChemoTech Welcomes Strategic Investors from the announce Directed Share Issue to Accelerate Global Growth

Scandinavian ChemoTech
Regulatory press release7/27/2025, 10:15 AM

Scandinavian ChemoTech AB (publ) carries out a directed share issue and receives approximately 4.85 MSEK

Scandinavian ChemoTech
Press release7/25/2025, 6:45 AM

(RETRANS) Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation

Scandinavian ChemoTech
Regulatory press release7/24/2025, 2:25 PM

Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation

Scandinavian ChemoTech
Press release7/2/2025, 6:45 AM

(RETRANS) ChemoTech's Animal Care Division Achieves Record-Breaking Sales in Q2 2025

Scandinavian ChemoTech
Regulatory press release7/1/2025, 2:45 PM

ChemoTech's Animal Care Division Achieves Record-Breaking Sales in Q2 2025

Scandinavian ChemoTech
Press release6/24/2025, 12:20 PM

ChemoTech: Full Management and Board Subscribes to the Warrant Program Adopted by the AGM

Scandinavian ChemoTech
Press release5/7/2025, 10:11 AM

Redeye: Scandinavian ChemoTech - Momentum continues

Scandinavian ChemoTech
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.